z-logo
Premium
Discussion of “A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III” by Andrew G. Chapple and Peter F. Thall
Author(s) -
Leifer Eric S.,
Geller Nancy L.
Publication year - 2019
Publication title -
biometrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.298
H-Index - 130
eISSN - 1541-0420
pISSN - 0006-341X
DOI - 10.1111/biom.12993
Subject(s) - biostatistics , medicine , library science , gerontology , epidemiology , computer science

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom